Nebulizer
Latest Novartis AG Patents:
- Modified release formulation for (-)-(3AR,4S,7AR)-4-hydroxy-4-m-tolylethynyl-octahydro-indole-1-carboxylic acid methyl ester
- Polyomavirus neutralizing antibodies
- Synthesis of prostate specific membrane antigen (PSMA) ligands
- Cell secreted minibodies and uses thereof
- Combination therapy using a chimeric antigen receptor
Description
The broken line showing in
Claims
The ornamental design for a nebulizer, as shown and described.
Referenced Cited
U.S. Patent Documents
Foreign Patent Documents
| D441069 | April 24, 2001 | Hammarlund et al. |
| 6578571 | June 17, 2003 | Watt |
| 7418962 | September 2, 2008 | Rao |
| 20050217666 | October 6, 2005 | Fink et al. |
| WO 2007/024812 | March 2007 | WO |
Patent History
Patent number: D591418
Type: Grant
Filed: Apr 10, 2008
Date of Patent: Apr 28, 2009
Assignee: Novartis AG (Basel)
Inventor: Glenn M. White (Felton, CA)
Primary Examiner: Ian Simmons
Assistant Examiner: Christopher Lee
Attorney: Michael Mazza
Application Number: 29/307,282
Type: Grant
Filed: Apr 10, 2008
Date of Patent: Apr 28, 2009
Assignee: Novartis AG (Basel)
Inventor: Glenn M. White (Felton, CA)
Primary Examiner: Ian Simmons
Assistant Examiner: Christopher Lee
Attorney: Michael Mazza
Application Number: 29/307,282
Classifications
Current U.S. Class:
Respirator, Vaporizer, Or Inhalation Tube (4) (D24/110)